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Abstract
Background: Chronic low back pain (CLBP) is a persistent disabling condition with rising
significant healthcare, social and economic costs. Current research supports the use of exercise-
based treatment approaches that encourage people with CLBP to assume a physically active role
in their recovery. While international clinical guidelines and systematic reviews for CLBP support
supervised group exercise as an attractive first-line option for treating large numbers of CLBP
patients at low cost, barriers to their delivery include space and time restrictions in healthcare
settings and poor patient attendance. The European Clinical Guidelines have identified the need for
research in the use of brief/minimal contact self-activation interventions that encourage
participation in physical activity for CLBP. Walking may be an ideally suited form of individualized
exercise prescription as it is easy to do, requires no special skills or facilities, and is achievable by
virtually all ages with little risk of injury, but its effectiveness for LBP is unproven.
Methods and design: This study will be an assessor-blinded randomized controlled trial that will
investigate the difference in clinical effectiveness and costs of an individualized walking programme
and a supervised general exercise programme compared to usual physiotherapy, which will act as
the control group, in people with chronic low back pain. A sample of 246 patients will be recruited
in Dublin, Ireland through acute general hospital outpatient physiotherapy departments that
provide treatment for people with CLBP. Patients will be randomly allocated to one of the three
groups in a concealed manner. The main outcomes will be functional disability, pain, quality of life,
fear avoidance, back beliefs, physical activity, satisfaction and costs, which will be evaluated at
Published: 2 July 2009
BMC Musculoskeletal Disorders 2009, 10:79 doi:10.1186/1471-2474-10-79
Received: 26 May 2009
Accepted: 2 July 2009
This article is available from: http://www.biomedcentral.com/1471-2474/10/79
© 2009 Hurley et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 11
(page number not for citation purposes)
BMC Musculoskeletal Disorders 2009, 10:79 http://www.biomedcentral.com/1471-2474/10/79baseline, and 3, 6 and 12 months [follow-up by pre-paid postage]. Qualitative telephone interviews
and focus groups will be embedded in the research design to obtain feedback about participants'
experiences of the interventions and trial participation, and to inform interpretation of the
quantitative data. Planned analysis will be by intention to treat (quantitative data) and thematic
analysis (qualitative data)
Discussion: The trial will evaluate the effectiveness of a walking programme and a supervised
general exercise programme compared to usual physiotherapy in people with CLBP.
Trial registration: Current controlled trial ISRCTN17592092
Background
Chronic low back pain (CLBP) is a persistent disabling
condition with rising significant healthcare, social and
economic costs [1,2]. Current research and both Euro-
pean and American Clinical Guidelines supports the use
of exercise-based treatment approaches that encourage
people with chronic low back pain (pain >3 months) to
assume a physically active role in their recovery [3-6].
However, these patients often report decreased habitual
physical activity levels, believing that if movement hurts
they may be re-injuring themselves, termed 'fear avoid-
ance'[7,8].
The recent European Clinical Guidelines for CLBP con-
cluded that supervised group exercise is an attractive first-
line option for treating large numbers of CLBP patients at
low cost [6]. The "Back to Fitness" physiotherapy-led
supervised group exercise programme for CLBP was intro-
duced in the UK in the 1990s [9]. Its effectiveness has
been supported in several RCTs, reporting significant
improvements in pain and disability compared to 'rou-
tine' physiotherapy (i.e. advice/education, passive mobili-
sation/manipulation)[10] and GP management [11], and
it has been shown to be cost effective[11]. Nonetheless, a
national survey by the Principal Investigator of public
general hospitals in the Republic of Ireland (ROI), found
that only 39% of responding physiotherapy departments
were delivering group-based exercise programmes for
CLBP, the main barriers being space and time restrictions,
and insufficient staffing levels [12].
Furthermore, another limiting factor from the patients'
perspective is poor adherence with the recommended
exercises [13], and the requirement for regular attendance
at the class with drop out rates of up to 30% being
reported in the literature [14]. Given the difficulties and
limited availability of supervised exercise programmes, an
alternative clinically and cost effective approach to
increasing the activity levels of patients with CLBP is war-
ranted.
The European Clinical Guidelines have identified the use
of brief/minimal contact self-activation interventions that
encourage participation in physical activity for CLBP as an
area for future research, particularly as this approach
could result in significant cost savings if it proves to be at
least as effective as other treatments [6]. For CLBP, there is
moderate evidence from RCTs [15,16] and a systematic
review [3] that brief information and advice to stay active
are more effective than usual GP care in reducing LBP-
related disability, but not pain levels. However, there is
limited evidence of the effects of self-activation interven-
tions compared to supervised exercise programmes on
pain and disability levels [17], and no evidence of the
effects of either type of programme in increasing CLBP
patients' level of participation in physical activities, return
to work rates or psychosocial variables compared to 'rou-
tine' physiotherapy.
Walking may be an ideally suited form of exercise pre-
scription as it is easy to do, requires no special skills or
facilities, and is achievable by virtually all ages with little
risk of injury [18,19]. General physical activity recom-
mendations encourage individuals to accumulate 30 min-
utes of moderate intensity physical activity on five days
per week [20] or 10,000 steps [21]; and there is evidence
from a meta-analysis that healthy but sedentary individu-
als who take up a programme of regular brisk walking
improve several known risk factors for cardiovascular dis-
ease [22]. There is limited evidence that people with LBP
are less physically active and have altered patterns of phys-
ical activity than matched controls [23,24]. Several recent
studies have reported that people with chronic LBP failed
to reach the recommended 10,000 steps per day and took
significantly less steps than healthy age-matched controls
[24,25].
There has been minimal investigation of the effectiveness
of walking programmes in LBP management. One RCT
found unsupervised walking at a self-selected pace was
less effective than individual physiotherapy or medical
exercise therapy in reducing pain, disability, costs and
increasing patient satisfaction levels in people with CLBP
[26]. Participants in the walking group were instructed to
walk for one hour three times per week at their conven-
ience, preferably on alternate days. However, apart from
one information session, participants in the walking
group received no further contact or support from a healthPage 2 of 11
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activity was not investigated. From a North American
study back pain sufferers who participated in brisk walk-
ing for at least 3 hours per week reported reductions in
low back pain, disability, and psychological distress [27].
Nonetheless, that trial was primarily designed to compare
chiropractic and medical care for LBP, and thus patients
did not receive any structured physical activity or exercise
interventions and no details of the walking intervention
are provided. Given the limited research to support or
refute walking programmes in CLBP management, there is
a need to investigate the effectiveness of such programmes
in people with chronic LBP.
For the researchers designing such walking programmes,
and the clinicians delivering them, the challenge is to
devise an effective intervention that will motivate habitu-
ally sedentary people with LBP to be physically active. A
Cochrane systematic review of interventions to promote
physical activity concluded that a mixture of self-direction
and on-going professional support can encourage adults
to be more physically active [28]. A randomised control-
led trial found that an eight-week low frequency progres-
sive walking programme for 'normal' sedentary adults had
high levels of adherence, and resulted in increased physi-
cal activity levels with no adverse effects or injuries, thus
increasing its clinical application [29]. Another trial
reported evidence for the benefit to fitness and cardiovas-
cular risk of the '30 minute brisk walking, five days per
week' message to people aged 50–65 years who partici-
pated in a 12 week unsupervised home-based walking
programme that used pedometers as motivational tools
[30]. Pedometers are simple to use, inexpensive devices
that produce a user-friendly output (step count, duration)
that serves as an effective motivator to increase physical
activity [31].
A self-activation programme by walking may be a more
pragmatic and less costly intervention than supervised
exercise classes to promote increased physical activity lev-
els in patients with CLBP. It has the additional advantages
of supporting a larger population of CLBP patients at the
same time, and by moving the emphasis away from the
hospital setting could reduce the costs to the Health Serv-
ice. Given that the majority of patients with CLBP cur-
rently receive a range of interventions within the scope of
'usual' physiotherapy (advice, passive mobilization/
manipulation, general exercise [32-34], this RCT will
establish the difference in effectiveness of a walking pro-
gramme and a supervised general exercise programme
compared to usual physiotherapy, which will act as the
control intervention, in subjects with chronic low back
pain.
The primary objective is to:
(i) determine the difference between groups in mean
change in functional disability at 6 months
The secondary objectives are to:
(ii) determine the difference between groups in mean
changes in pain, health-related quality of life, psycho-
social beliefs, days of sick leave, daily physical activity
levels, self efficacy, readiness to change and patient
satisfaction
(iii) determine the difference between groups in cost
utility and the cost effectiveness of the alternative
treatment programmes
(iv) determine the difference between groups in level
of adherence to each intervention
(v) complete a qualitative exploration of subjects
experience of each intervention
Hypotheses Tested
The trial will test two 'null' hypotheses. The primary null
hypotheses is that,
(a). in people referred for physiotherapy for chronic LBP
there is no difference in clinical outcome and costs
between those receiving a walking programme, a super-
vised general exercise programme and usual physiother-
apy;
The secondary null hypothesis is that:
(b). subjects that have received a walking programme or
supervised general exercise programme will not have
changed daily physical activity levels compared to those
who have received usual physiotherapy
Methods/design
The Research Ethics Committees of the participating Dub-
lin hospitals have granted approval for this study:
1. Adelaide and Meath Hospital incorporating the
National Children's Hospital
2. Beaumont Hospital
3. Connolly Hospital
4. Mater Misericordiae University Hospital
5. St Vincent's University Hospital
The trial will be reported according to the recommenda-
tions of the CONSORT statement [35] and the flow of par-Page 3 of 11
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quantitative study will establish the difference in clinical
effectiveness and costs of a walking programme and a
supervised general exercise programme compared to
usual physiotherapy, which will act as the control inter-
vention, for patients with chronic low back pain. The
qualitative study will explore participants' experience of
the study and the interventions.
Quantitative study
Design
The study will be a prospective randomized controlled
trial (RCT) with three arms (i) walking programme, (ii) a
supervised exercise class, (iii) usual physiotherapy of up
to 8 weeks duration. Outcomes will be assessed at base-
line and 3, 6 and 12 months [follow-up by pre-paid post-
age].
Controlling bias
The RCT design includes key methodological features that
have been recognized as important in minimizing bias in
clinical trials: true randomization, concealed allocation,
specification of eligibility criteria, blind outcome assess-
ment, blind analysis and intention-to-treat analysis.
Setting
A sample of patients will be recruited in Dublin, Ireland
through the physiotherapy departments of acute public
hospitals that provide physiotherapy treatment for people
with CLBP.
Participant flow through the RCT (based on CONSORT statement)Figure 1
Participant flow through the RCT (based on CONSORT statement).
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The following mechanisms will be used to ensure the trial
protocol is applied consistently: protocol manuals will be
developed and all involved researchers and clinicians will
be trained to ensure that subject screening, assessment,
random allocation and treatment procedures are con-
ducted according to the protocol; a random sample of
20% of treatment records in each group will be audited by
a researcher not involved in the day to day running of the
trial to check that treatment is administered as per the pro-
tocol; if any anomalies are found all treatment records
will be checked. The treatment record forms will be com-
pleted by clinicians on every patient recruited to the study.
Study population and recruitment
Clinics and Clinicians
The study will be conducted in several Dublin metropoli-
tan acute general hospitals physiotherapy departments
that provide rehabilitation for musculoskeletal condi-
tions. The relevant hospitals will be contacted by tele-
phone and email seeking expressions of interest to
participate in the study. A meeting will be scheduled with
each hospital's physiotherapy department manager to
outline the project and distribute the outline protocol.
Information meetings will be arranged with managers and
treating physiotherapists to discuss the study background,
aims and methodologies and to address their queries.
Reception staff will be briefed on the study recruitment
process, and patient appointment systems, paperwork
and filing arrangements will be made. All participating
physiotherapists involved in the interventions will attend
training days in the School of Physiotherapy and Perform-
ance Science, University College Dublin. These days will
be delivered by various members of the research team. The
main focus of the training days will be to ensure that the
interventions are standardized across all centres. A cogni-
tive behavioural therapy (CBT) approach will be empha-
sized and performance indicators will be set for the
physiotherapists to further ensure homogeneity of the
active interventions.
In advance of the training days, a detailed trial manual
will be distributed to the therapists. Their role in the study
will be highlighted. They will also complete the PABs PT
(Pain Attitudes and Beliefs of Physiotherapists) Question-
naire to establish their biopsycho-social or biomedical
orientation to the management of CLBP [36].
Patients
All eligible patients with chronic or recurrent LBP referred
to the participating hospitals physiotherapy departments
by general practitioners or hospital consultants will be
invited to participate in the study by the Trial Co-ordina-
tor in order of referral until adequate subject numbers are
achieved. Patients will receive the initial contact by tele-
phone to explain the trial procedures, to clarify interest
and to screen eligibility, and will then be followed up by
a letter containing the patient information sheet and an
invitation to attend for baseline assessment. Suitable,
interested patients will attend the relevant hospital's phys-
iotherapy department, where detailed verbal explanations
of the study protocol will be provided and, written
informed consent will be sought by the Trial Co-ordina-
tor. The Trial Co-ordinator will record the number of
patients invited, the number who declined, ineligible
patients and reasons.
Eligibility Assessment
Clinicians
Chartered Physiotherapists who are eligible for member-
ship of the Irish Society of Chartered Physiotherapists and
are employed by one of the participating hospitals are eli-
gible to participate.
Patients
At the initial telephone contact and the baseline interview
the Trial Co-ordinator will use a screening checklist to ver-
ify eligibility (Table 1). The Physical Activity Readiness
Questionnaire (PAR-Q)[37] will be completed to deter-
mine whether medical clearance is necessary before trial
participation.
Randomisation
Patients who have consented to participate will be ran-
domly allocated in accordance with recognised proce-
dures, by computer-generated random allocation
sequences that will be prepared centrally by the trial stat-
istician. This sequence will be used to randomly allocate
each consenting, numbered subject to one of three study
groups: supervised exercise class, walking programme or
usual physiotherapy.
Stratification will be by hospital only and separate ran-
domisation lists will be used for each hospital. Prior to
randomisation each subject's group allocation preference
will be sought and recorded by the Trial Co-ordinator in
order to investigate whether treatment preference has any
influence on outcomes.
The Trial Co-ordinator will telephone/text the Research
Administrator who will provide a central, remote, tele-
phone randomisation service, to obtain each consecutive
subject's random group allocation. Following the baseline
assessment an appointment for the relevant intervention
will then be made by the Trial Co-ordinator. Each partici-
pant will receive a copy of 'The Back Book'[38] and be
advised to read it before the first physiotherapy appoint-
ment. Participants allocated to the WP will be given an
educational walking manual, and a Yamax Digiwalker
Pedometer, instructed in its use and requested to wear itPage 5 of 11
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daily activity levels (frequency of walks, walk duration) in
an exercise diary prior to the start of the intervention.
Blinding
Clinicians
Due to the nature of the interventions it will not be possi-
ble to blind the participating clinicians to the group allo-
cation of patients, but clinicians will not be involved in
outcome assessment.
Patients
Due to the nature of the interventions it will not be possi-
ble to blind patients to their group allocation. The patient
information leaflet will inform participants that they have
an equal chance of receiving one of three physiotherapy
approaches for low back pain management.
Assessors
A blinded researcher will administer all outcome meas-
ures for postal follow-up. The Trial Co-ordinator will not
be involved in follow-up outcome assessment. The statis-
tician will be unaware of group allocation until comple-
tion of data analyses.
Sample Size
A total of 189 patients (n = 63 per group) will be required
for 80% power to detect a 4 point difference between
groups on the primary outcome, the Oswestry Disability
Index [39], with 95% confidence using a two-tail
between-within repeated measures ANOVA test of differ-
ence between group means. Based on the results of previ-
ous LBP trials investigating exercise [11] and using postal
follow-ups [40], we anticipate a 30% loss to follow-up.
Thus we aim to recruit 82 subjects per group (total 246
subjects).
Outcome Measures
At the baseline assessment sociodemographic data (i.e.
age, gender, education level, social status, occupation and
work status, past medical history, LBP history), cardiores-
piratory fitness using the shuttle walk test [41], blood
pressure, Body Mass Index (BMI, kg/m2) and any previous
treatment will be documented by the Trial Coordinator. A
combination of recommended self-report valid and relia-
ble outcome questionnaires [42] detailed below, and
objective measurement will be used at baseline and fol-
low-up (3, 6 and 12 months). The satisfaction question-
naire will only be administered at the end of scheduled
intervention period (3 months).
Table 1: Eligibility Criteria for the SWIFT Trial
Inclusion criteria Exclusion criteria
Patients with chronic (³3 months) or recurrent (³3 episodes in previous 
12 months) LBP of mechanical origin with/without radiation to the 
lower limb
Currently or having received treatment for CLBP within previous 3 
months
Males/females between 18–65 years Red flags indicating serious spinal pathology, e.g. cancer, cauda equina 
lesion
No spinal surgery within the previous 12 months Radicular pain indicative of nerve root compression
Patients deemed suitable by their GP/hospital consultant to carry out an 
exercise programme
Patients diagnosed with severe spinal stenosis, spondylolisthesis, 
fibromyalgia
Patients willing to attend for an 8-week treatment programme of 
exercise classes
History of systemic/inflammatory disease, e.g. rheumatoid arthritis
Access to a telephone (for follow-up support) Patients with any confounding conditions such as a neurological disorder 
or currently receiving treatment for cancer
Fluency in English (verbal and written) Patients with acute (< 6 weeks) or subacute LBP (6–12 weeks), provided 
that they have experienced < 3 LBP episodes during previous 12 months
'Low' or 'moderate' levels of physical activity measured by the IPAQ 
(< 600 MET-minutes/week)
Unstable angina/uncontrolled cardiac dysrhythmias/severe aortic 
stenosis/acute systemic infection accompanied by fever
Medico-legal issues
PregnancyPage 6 of 11
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The primary outcome measure will be a change in:
(i) Functional disability due to LBP measured by the
Oswestry Disability Index (ODI) [43]
The secondary outcome measures will be changes in:
(ii) Pain using Numerical Rating Scales for current and
worst pain [44]
(iii) Health-related quality of life measured by the Euro-
Qol questionnaire [45]
(iv) Psycho-social beliefs using the Fear Avoidance
Beliefs Questionnaire [46] and the Back Beliefs Ques-
tionnaire [47]
(v) Employment status and number of days reported sick
leave over the past year for those in paid employment
only
(vi) Self-report physical activity levels using the Interna-
tional Physical Activity Questionnaire (IPAQ) [48],
(vii) Objective physical activity levels using an activPal™
device: a valid and reliable measure of walking that is
capable of recording steps, time spent lying/sitting,
standing and stepping under free living conditions
[49] previously used by some of the authors in
another LBP trial [50]. A sample of convenience of
participants from each group will be requested to wear
the activPAL™ on 3 separate occasions each lasting 7
days (1) at baseline, (2) 3 months and (3) 6 months
after initial randomisation.
(viii) Self efficacy questionnaire [51]
(ix) Readiness to change questionnaire [52]
(x) Patient satisfaction will be assessed using Likert
scales assessing satisfaction with outcome and satisfac-
tion with care at 3 months [53]
Cost Outcomes
Two cost outcomes will be used
(i) Participants resource utilization will be assessed using
cost diaries developed and successfully used by the
Principal Investigator in a previous RCT [54]. A ran-
dom sample of 20% of cost diaries in each group will
be verified by telephone interview with a researcher
not involved in the day to day running of the trial to
check the accuracy and ensure the quality of the data.
(ii) Participant's health state will be assessed using the
EuroQol (EQ-5D) Questionnaire's Weighted Health
Index [45] and Visual Analogue Scale.
Follow-up reminders will be given by phone and com-
pleted questionnaires returned by pre-paid envelopes.
Interventions
(i) Supervised exercise class (SEC)
Within one week of randomisation, participants will com-
mence the SEC. This class will follow a group-based for-
mat based on the 'Back to Fitness' programme used in the
UK BEAM trial [9-11,13,14] which is underpinned by cog-
nitive behavioural therapy principles designed to change
participants behaviour by modifying their attitude to their
LBP, i.e. 'hurt' does not mean harm [7,8]. First, each par-
ticipant will attend the physiotherapy department for an
initial individual assessment with the Chartered Physio-
therapist delivering the class, where there will be discus-
sion and agreement between the therapist and the patient
on short and long-term goals; recording of the patient's
exercise capabilities and perceived barriers to recovery and
the individual's treatment expectations. Second, partici-
pants will attend the physiotherapy department of the rel-
evant participating hospital once a week for 8 weeks for a
one-hour supervised group exercise class led by a Char-
tered Physiotherapist. The physiotherapist will advise
patients according to their individual goals and exercise
capabilities, and help identify which exercise(s) they
could continue independently of the treatment sessions,
i.e. foster the development of self-management strategies.
Subjects will also be required to rate their perceived exer-
tion during the class on the Borg scale – a linear scale
measuring level of breathlessness from 0= 'not breathless
at all' to 10 = 'maximal'. [55,56]. Patients will be encour-
aged to accept responsibility for determining and carrying
out their weekly programme of activity. Adherence with
the supervised exercise programme will be recorded as the
number of sessions attended. The number of sessions
defined as adherence will be decided on completion of
the trial.
(ii) Walking programme (WP)
Within one week of randomisation, participants will com-
mence the WP, the focus being to increase physical activity
through a graded walking programme. The WP is based
on previous effective programmes in healthy sedentary
adults [29,30,57,58] as no previous programmes for LBP
are available.
As with the SEC, each participant will attend the physio-
therapy department for an initial individual assessment,
where there will be discussion and agreement between the
therapist and the patient on short and long-term goals;
recording of the patient's exercise capabilities and per-Page 7 of 11
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expectations. The therapist will use the information
recorded in the exercise diary to inform the starting point
for the eight week progressive WP; the minimum being a
10 minute walk (approx 1200 steps) on at least four days
per week to be decided with, where possible, one day's rest
between walks. The aim of the programme is to progress
to the American College of Sports Medicine guidelines of
30 minutes moderate intensity walking on five days per
week by week five [20], and then to maintain this level for
the remainder of the programme. The 30 minutes brisk
walking may be accumulated in two or three shorter bouts
if this is more attainable e.g. three 10 minute walks
[30,58]. A recent review found no difference in the posi-
tive effects on cardiovascular fitness of empirical studies
of accumulated or continuous physical activity in seden-
tary adults and highlighted the need for research to evalu-
ate if accumulated exercise may increase compliance in
previously sedentary adults [59]. All participants will be
encouraged to use the Borg Breathlessness scale to estab-
lish their walking speed: targeting level three (moderate
breathlessness) to four (somewhat severe), the minimum
level required to achieve the benefits related to exercise
[55,56].
Participants will be contacted once per week by telephone
by the Chartered Physiotherapist who performed the ini-
tial assessment to progress their walking frequency and
duration based on their exercise diary record of the previ-
ous week's walking, and to provide encouragement. These
telephone calls will be based around a specifically devel-
oped telephone script based upon CBT principles. Partici-
pants will be advised that just like athletes, any
unaccustomed exercise is likely to produce some muscle
soreness [8]. Participants will use their Yamax Digiwalker
Pedometer [60] as a motivational feedback tool, provid-
ing immediate information on activity levels [61].
Adherence with the walking programme will be assessed
by the frequency, distance, number of steps taken and
duration of walks recorded in the exercise diary. Specific
adherence levels will be established once the trial is com-
plete. At the end of the intervention subjects will reattend
the physiotherapy department for a review appointment
with a view to discharge from physiotherapy.
(iii) Usual Physiotherapy (UP) -Control Group
Within one week of randomization, participants will com-
mence individual usual physiotherapy at the discretion of
the treating physiotherapist in the participating hospital.
All physiotherapy treatments and the number of visits will
be recorded for the study period in previously designed
treatment record forms. On the basis of a previous RCT by
the Principal Investigator in the Republic of Ireland public
physiotherapy health service the anticipated mean (SD)
number of treatments is 5.8 over a mean (SD) of 7.7
weeks (5.8) weeks [54]. A multimodal approach of educa-
tion/advice, manipulative therapy and exercise therapy
will be permitted on the basis of the results of previous
surveys of physiotherapy practice in the UK and Ireland
[32-34]. As part of this it is expected that subjects will be
provided with an individualized exercise programme at
the discretion of the treating therapist but will not be per-
mitted to attend group exercise class or undertake a walk-
ing programme during the trial. Adherence will be
assessed by the number of visits prior to discharge from
physiotherapy.
Adverse effects or events
No adverse events, apart from minor musculoskeletal
complaints in the WP group, are anticipated but will be
documented by type, length of time, and frequency
should they occur [62].
Data Analysis
Analysis will be by intention to treat. All participants and
group allocation will be coded, sociodemographic data
coded, and outcome questionnaires scored, and all data
entered into the Statistical Package for the Social Sciences
database for analysis following data cleaning and check-
ing for errors. Analysis of the clinical outcome data will be
performed by the statistician who will remain blinded to
group identification until analysis is complete. Between
group analyses will be performed to test for between
group differences in each outcome from baseline at fol-
low-up. Continuous outcome variables will be analysed
using a mixed between-within repeated measures analysis
of variance if the assumptions for parametric statistics
hold. If substantial evidence of non-normality is found
appropriate alternative (non-parametric) tests will be
applied, and specified as the primary analysis method.
Using data from the cost diaries, the extent to which each
of the interventions has impacted on subsequent use of
health care will also be calculated and will cover all iden-
tifiable health care costs. The direct and indirect costs to
patients receiving each intervention will be obtained. The
health care services costs incurred during the intervention
and year to follow up will be calculated using the relevant
observable prices. Where prices cannot be observed
shadow prices will estimated; mean and median health
care utilization rates and associated direct service costs in
addition to indirect and direct patient costs will be calcu-
lated for both intervention groups. Relationships between
presenting LBP severity and utilization/cost will be inves-
tigated. An additional cost effectiveness analysis will use
the magnitude of a mean and median change on the
Oswestry Disability Questionnaire as the natural unit of
outcome.
The resulting scores from the EQ-5D health state and the
visual analog scale will be used to generate the health statePage 8 of 11
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ysis (CUA). The CUA will allow the outcomes of this study
to be compared to other studies allowing the relevant
short term benefit of the interventions to be assessed.
Qualitative study
A sample of participants from each group will be invited
to participate in a semistructured telephone interview or
to attend a focus group (one per intervention) at the end
of the 6 month follow-up. These subjects will be contacted
by letter and invited to contact the Trial Co-ordinator if
they wish to participate. Both the focus group and tele-
phone interviews will be conducted by an experienced
interviewer with a predetermined set of questions. A "clue
and process" format using a checklist of topics, will be
used to ensure that the same basic areas are covered but
allowing any issues of importance to the participants to
emerge. The sessions will be audiotaped, minuted and
transcribed verbatim for independent analysis of emer-
gent themes. The main areas to be explored will be sub-
jects' reasons for participation in the trial, their
interpretation of study information and documentation,
their experiences, expectations and satisfaction with the
programme of care including barriers/motivators to par-
ticipation in the relevant programme.
Data Analysis
Qualitiative data from the telephone interviews and focus
groups will be analysed using Burnard's thematic analysis
[63]. Emerging themes will be identified and comparisons
explored between patients' experience of trial participa-
tion, their perception of treatment effectiveness and
response to each intervention, its impact, motivators and
barriers to adherence, as well as their expectations and
treatment preferences. A random sample of transcripts
from each group will be selected and reviewed by an inde-
pendent researcher not otherwise involved in the study for
inter-rater and intra-rater reliability of identified themes.
Discussion
We have presented the rationale and design of a ran-
domised controlled trial, with embedded qualitative and
economic studies, to investigate and evaluate the differ-
ence in effectiveness of a walking programme and a super-
vised general exercise programme compared to usual
physiotherapy, which will act as the control intervention,
in subjects with chronic low back pain. The results of this
study will be presented as soon as they are available.
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